Urgent treatment solutions are needed for children, adolescents and adults with mental health conditions. Despite the government committing to spending 8.9% of all NHS funding on mental health treatment last year, the pipeline to build new facilities and train new staff will take years and, on their own, are insufficient to meet demand.
A suite of online therapies, developed and clinically validated by expert teams at the University of Oxford’s Experimental Psychology and Psychiatry Departments, is now available to help close this gap in care, and tackle anxiety disorders and mental health conditions across all age groups from children through to adolescents and adults. Patients work through a series of online modules with the brief support of a therapist through short phone or video calls and messages.
Randomised clinical trials by the University of Oxford team have demonstrated the impact of all four of the online platforms. Excellent results led to a new commercial licence partnership negotiated between Oxford University Innovation and Koa Health, a company well placed to leverage this cutting-edge technology and research. Koa Health looks forward to making the programmes available to patients across many NHS services, beginning in West Sussex, Oxfordshire, Buckinghamshire, Leicestershire, Bradford, North Tyneside, and London.
more recommended stories
Invasive Cosmetic Procedures Raise Patient Safety ConcernsKey Summary Experts publishing in The.
Oligometastatic Pancreatic Cancer: New Global ConsensusKey Points Summary An international expert.
Endometriosis Screening Tool May Cut Diagnosis DelaysKey Points Researchers from the University.
Influenza Vulnerability Index Maps Flu Risk Across US StatesKey Points Researchers developed a new.
Post Amputation Pain Patterns Differ by Prosthetic TypeKey Summary A new study from.
Diabetic Kidney Disease: Combo Therapy Targets Zombie CellsKey Points Researchers from Mayo Clinic.
Heart Attack Recovery: Single Injection May Heal the HeartKey Points Researchers have developed a.
Fragmentome Technology Detects Early Liver FibrosisKey Points at a Glance AI-based.
CTNNB1 Syndrome Study Explores Beta-Catenin DefectsKey Takeaways Researchers in Spain are.
Tuberculosis Breakthrough with Experimental AntibioticsKey Takeaways Experimental antibiotics disrupt a.
Leave a Comment